IT業の多くの人がいくつか認証試験にパスしたくて、それなりの合格証明書が君に最大な上昇空間を与えます。この競争の激しい業界でとんとん拍子に出世させるのはSalesforceのALS-Con-201認定試験ですが、簡単にパスではありません。でもたくさんの方法があって、最も少ない時間をエネルギーをかかるのは最高です。
| Section | Weight | Objectives |
|---|---|---|
| Topic 1: Life Sciences Industry Overview and Salesforce Agentforce for Life Sciences | 15% | - Describe how Agentforce applies to Life Sciences use cases - Explain key regulatory compliance requirements (FDA, GxP, HIPAA) - Understand Life Sciences industry processes (pharmaceutical, biotech, medical device) |
| Topic 2: Discovery and Requirements Gathering | 20% | - Document functional and technical requirements - Map business processes to Salesforce Agentforce capabilities - Assess data quality and integration needs - Identify stakeholder requirements for Life Sciences implementations |
| Topic 3: Compliance and Security | 20% | - Implement data security for HIPAA compliance - Configure audit trails and tracking for FDA requirements - Set up data partitioning for multi-tenant pharmaceutical environments - Apply Field Audit Trail for regulated data |
| Topic 4: Solution Design and Configuration | 25% | - Configure Salesforce Health Cloud for Life Sciences - Design integration with external Life Sciences systems - Build automation flows for compliance workflows - Design Agentforce solutions for Life Sciences scenarios - Implement Agentforce AI agents for clinical trial support |
| Topic 5: Testing, Deployment, and Enablement | 20% | - Create documentation for regulated environments - Establish support processes for post-production compliance - Develop training materials for Life Sciences users - Plan and execute testing strategies for Life Sciences solutions - Deploy Agentforce solutions following validation requirements |
ALS-Con-201学習教材は、すべての人々がALS-Con-201証明書を求めて戦うのを支援し、新しいスキルの開発を支援することを目的としています。この競争の激しい世界で生き残りたいのであれば、現代の企業の要件に適応する包括的な開発計画が必要です。長年にわたる献身と品質保証のために、ALS-Con-201準備試験をお勧めします。 ALS-Con-201学習教材の無料デモを無料でダウンロードして、ALS-Con-201試験問題がどれほど優れているかを知ることができます。
質問 # 47
Choose 1 option.
An Agentforce Life Sciences Consultant needs to configure sample management rules. They must specify which types of Healthcare Organizations (HCOs) are eligible to receive samples and enforce that users must enter a batch number for every sample dropped.
Which subsection of Visit Settings should the consultant use for these configurations?
正解：B
解説：
The correct answer is C because the requirement is about sampling eligibility and validation behavior during visits. Salesforce Life Sciences sample management features support compliant handling and distribution of samples, and visit-related sample behavior is configured through visit settings and sample management setup. Salesforce Help describes sample management as enabling pharmaceutical companies to efficiently handle and distribute drug samples to providers, while the broader Customer Engagement setup includes Life Sciences mobile and visit configuration areas where these rules are applied.
The scenario includes two validation-style requirements. First, the consultant must specify which types of HCOs are eligible to receive samples. Second, the system must require users to enter a batch number for every sample drop. Both requirements are about enforcing rules during the sampling process, not about presenting product details or general sample item display.
Option A, Product Detailing Settings, is incorrect because product detailing is used to configure how products are discussed or presented during an engagement. It does not control HCO sample eligibility or mandatory batch entry. Option B, Samples and Items Settings, sounds related to sample availability, but the requirement is specifically about compliance validation. Option C, Sample and Validation Settings, is the correct subsection because it governs sample-related validation behavior, including eligibility and required information such as batch number entry. Therefore, the consultant should use Sample and Validation Settings.
=========
質問 # 48
Choose 1 option.
Cumulus Pharma is preparing for the commercial launch of a new product, "Immunexis." The sales operations director wants to implement a strategic sampling control that is not required by law, but is critical for inventory management. The requirements for this rule are:
Period Logic: The limit period must dynamically begin on the Product Launch Date rather than the standard Calendar Year.
Enforcement: To avoid blocking sales momentum, the system must only display a warning, or soft limit, if a rep exceeds the allocated quantity, allowing the rep to proceed with the disbursement if necessary.
Which Sample Limit Template type meets these requirements?
正解：B
解説：
Option C is correct because Advanced Sample Limit Templates are designed for custom, complex sample-limit rules. Salesforce Help explains that advanced sample limit templates are used to define custom sample limit rules for more complex needs and stricter requirements. This scenario requires two non-basic behaviors: a dynamic period start based on the product launch date and soft-limit enforcement that warns the rep but still allows the disbursement to proceed. Those requirements go beyond a generic calendar-year rule.
A Generic Sample Limit Template is not the best answer because generic templates are better suited for standard sample-limit logic. The requirement explicitly says the limit period must begin on the Product Launch Date rather than the standard Calendar Year, which makes the rule more specialized. A Country Sample Limit Template is also not correct because country templates are used for country-specific legal or regulatory sampling limits. In this question, the control is strategic and inventory-driven, not a legal requirement tied to a specific country.
Advanced templates are the correct fit because they allow more flexible configuration for business-specific sample controls, including nonstandard periods and warning-based enforcement. Therefore, the consultant should use an Advanced Sample Limit Template for the Immunexis launch sampling rule.
=========
質問 # 49
Choose 1 option.
A field sales rep bulk deletes several planned visits from the calendar for an upcoming week and then notices that two visits still appear on the calendar.
Why are these visits still visible?
正解：A
解説：
The correct answer is C because Life Sciences Calendar can display visits where the user is not the owner but is included as an attendee or visitor. Salesforce Life Sciences Visit Management supports adding internal users as visitors to a visit so that colleagues participating in the same HCP interaction can be recorded and the visit can be shared with them. Salesforce also describes Life Sciences Calendar as a place to visualize and prioritize key activities, including visits and other events, and Trailhead explains that reps can view colleagues' visits in shared calendars to coordinate engagement.
In this scenario, the rep bulk deleted several planned visits from their calendar. The two remaining visits are likely not visits owned and managed by the rep. Instead, they are visits owned by another user where the rep is included as an attendee. Because the calendar is configured to show attendee visits, those records continue to appear even after the rep deletes their own planned visits.
Option A is incorrect because the issue is not tied to the selected account list. Option B is plausible for some filtered-calendar behavior, but the key clue is that only some visits remain visible after bulk deletion. The standard Life Sciences explanation is that attendee visits can remain visible because they belong to a colleague and are displayed for collaboration. Therefore, the visits remain because the rep is added as an attendee.
=========
質問 # 50
Choose 1 option.
Cumulus Pharma requires the Agentforce Life Sciences for Customer Engagement Account Summary to include historical data from the Account record and related Healthcare Provider and Contact Point Address records.
Which configuration defines the object relationships for this summary?
正解：A
解説：
Option A is correct because Account Summarization uses a cross-object graph to define which objects and relationships are included in the generated summary. Salesforce Help states that administrators can create cross-object graphs from a predefined Account Summarization template to provide a complete view of an account and its related objects. This directly matches the requirement to include Account data and related Healthcare Provider and Contact Point Address information in the summary.
The phrase "historical data" is also important. Salesforce Account Summarization setup includes configuring history tracking for the fields included in the template, so Agentforce can summarize recent changes from the selected objects and fields. The cross-object graph defines the relationship structure, while field history tracking provides the change history used in the summary.
Option B, Actionable Relationship Center, is not the best answer. Actionable Relationship Center is used to visualize related records and relationships, but the Account Summary configuration specifically relies on cross-object graphs. Option C, Affiliation Alignment Rules, is unrelated because those rules support territory alignment for affiliated accounts, not Account Summary object relationships. Therefore, the consultant should use a Cross-Object Field History Graph to define the Account, Healthcare Provider, Contact Point Address, and related-object structure used by Agentforce Account Summary.
=========
質問 # 51
Choose 1 option.
Cumulus Pharma notices that synchronization transactions have failed, impacting sales users' ability to view recently created records offline in the Agentforce Life Sciences mobile app.
What should an Agentforce Life Sciences Consultant recommend to identify potential synchronization transaction failures?
正解：C
解説：
The correct answer is C because Salesforce Life Sciences synchronization management guidance specifically positions Simulation Mode as the tool used to proactively identify and fix potential synchronization problems before they affect end users. Salesforce describes synchronization management as a way to ensure efficient synchronization by resolving errors quickly and using Simulation Mode to find potential problems before they impact users.
In this scenario, sales users are unable to view recently created records offline in the Agentforce Life Sciences mobile app because synchronization transactions have failed. Offline mobile availability depends on successful synchronization between Salesforce and the mobile app. A consultant should therefore recommend testing synchronization behavior in Simulation Mode, because it helps validate whether records, transactions, and configuration changes will synchronize successfully before users rely on them in the field.
Option A is not the best answer because Event Monitoring Logs are broader Salesforce security and activity logs; they are not the recommended Life Sciences-specific mechanism for proactively identifying synchronization transaction failures in the offline mobile synchronization process. Option B is also incorrect because warning emails notify users or administrators after certain conditions occur, but they do not test synchronization transactions or identify potential sync failures before users are affected. Simulation Mode is the most targeted and preventive administrative tool for this issue.
質問 # 52
......
ALS-Con-201認証試験に合格することは他の世界の有名な認証に合格して国際の承認と受け入れを取ることと同じです。ALS-Con-201認定試験もIT領域の幅広い認証を取得しました。世界各地でALS-Con-201試験に受かることを通じて自分のキャリアをもっと向上させる人々がたくさんいます。Fast2testで、あなたは自分に向いている製品をどちらでも選べます。
ALS-Con-201模擬対策問題: https://jp.fast2test.com/ALS-Con-201-premium-file.html